Back to Search Start Over

[Anti-MOG associated disease].

Authors :
Lerusse J
Uginet M
Théaudin M
Bernard-Valnet R
Pot C
Lalive PH
Source :
Revue medicale suisse [Rev Med Suisse] 2024 Apr 24; Vol. 20 (871), pp. 828-832.
Publication Year :
2024

Abstract

Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease (MOGAD) is an autoimmune disease responsible for demyelination of the central nervous system that can occur in adults or children. Overlapping phenotypes between MOGAD, multiple sclerosis (MS) and neuromyelitis optica spectrum disease (NMOSD) have been described. The diagnostic criteria for MOGAD were proposed by a panel of international experts and published in 2023. Defining clinical, biological and imaging characteristics specific to this entity helps to improve diagnostic specificity. In this article, we present the clinical characteristics suggestive of MOGAD and discuss the importance of the antibody detection method and therapeutic management.<br />Competing Interests: Les auteurs n’ont déclaré aucun conflit d’intérêts en relation avec cet article.

Details

Language :
French
ISSN :
1660-9379
Volume :
20
Issue :
871
Database :
MEDLINE
Journal :
Revue medicale suisse
Publication Type :
Academic Journal
Accession number :
38665102
Full Text :
https://doi.org/10.53738/REVMED.2024.20.871.828